XORTX Therapeutics Inc. filed a Form 6-K on April 17, 2025, indicating its compliance with SEC reporting requirements. This event is neutral and not significant from an investor's perspective.
AI Assistant
XORTX THERAPEUTICS INC
2025
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.